Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.
about
Environmental enteropathy: critical implications of a poorly understood condition.Diagnosis and management of functional symptoms in inflammatory bowel disease in remissionHow to predict clinical relapse in inflammatory bowel disease patientsOptimizing biologic treatment in IBD: objective measures, but when, how and how often?Disease monitoring in inflammatory bowel diseaseClinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel diseaseMeasuring disease activity in Crohn's disease: what is currently available to the clinician.Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn's disease after ileocolonic resection: A prospective pilot study.Biomarkers of inflammatory bowel disease.A prospective single centre pilot evaluation of a serum calprotectin assay in unselected GI patients.The role and utility of faecal markers in inflammatory bowel disease.Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study.Fecal Calprotectin is an Accurate Tool and Correlated to Seo Index in Prediction of Relapse in Iranian Patients With Ulcerative Colitis.Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological studyProgress in the treatment and outcome of pediatric inflammatory bowel disease patients.The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease.Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease.Utility of faecal calprotectin analysis in adult inflammatory bowel disease.Cost utility of inflammation-targeted therapy for patients with ulcerative colitis.Taking Crohn's disease personallyEnvironmental Enteric Dysfunction in Children.The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease.Increased Enterococcus faecalis infection is associated with clinically active Crohn disease.Faecal levels of calprotectin in systemic sclerosis are stable over time and are higher compared to primary Sjögren's syndrome and rheumatoid arthritis.Management of Crohn's disease in poor responders to adalimumab.Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: A pilot study.Recommendations for identifying Crohn's disease patients with poor prognosis.Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.Biomarkers in management of inflammatory bowel disease.Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.Role of biomarkers in the study and management of inflammatory bowel disease: a "nonsystematic" review.Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease.The clinical value of faecal calprotectin and lactoferrin measurement in postoperative Crohn's disease.Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review.Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted Therapy.Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy.Luminally expressed gastrointestinal biomarkers.Compliance with the faecal calprotectin test in patients with inflammatory bowel disease.Monitoring and detection of disease recurrence after resection for Crohn's disease: the role of non-invasive fecal biomarkers.
P2860
Q24606211-3D8CAF7E-B831-4176-A753-DF34C71B90E2Q26768264-5F525633-F981-49A9-92BD-C7E427721AADQ26774575-93B6A46F-298B-451A-B98C-FFF733D0A7A5Q26775064-EDD7D65E-7AEE-4F38-AD01-36F804FA8C70Q26777553-65C5DEDC-79C2-4B3D-B777-156D98181D3FQ28072104-F6C8E200-B41A-4A10-A0DA-21A076E223A4Q28080934-D6727C45-0803-4975-8D72-9E9636E46D04Q33668961-2F15E17D-496D-46F5-8DF4-320048A3CA8EQ33695435-685F380B-41FC-4963-8684-0EA96E58BB78Q33746983-B4B5AABC-1824-456C-84FB-09B2F508490CQ33824685-53D42AAA-F907-49AF-92CE-BC4CA0CA80A1Q34456258-AF2E0A64-E1CA-4FE6-B072-8991C224CBD9Q35044223-D5C02C6D-F395-4B9E-A80E-B39D90324564Q35157904-5735A2B0-6D49-4695-A043-651701A349BBQ35177554-FC506CBC-0493-43C9-A9B3-E10DE7256126Q36056969-854098E4-8413-4921-8EA9-635B9E928A1CQ36150080-213CE749-38D5-47A5-8E0C-D03FD6FF6696Q36157891-62A23D31-AACA-4937-957E-79A7AD8E43B0Q36461010-DC0BF67B-7510-49DA-AA96-31635D36F338Q36815176-64A0A29B-C428-4D45-B29E-23BF3C402FB7Q36919248-10E3A604-BACB-41EC-B6F8-A47502F38638Q37037319-EC15DCBB-CB59-4A4A-B5DC-2A4E21FC1E1FQ37329989-FD7AC837-E1FD-41DB-8F0B-719A62251808Q37605952-C204A3D6-B005-416D-B84B-59D0D5457692Q37689925-BD6B62F7-20CA-4C0B-A44E-65B4E4AE836FQ37708656-CB9B6410-7483-451D-85CE-8EA741E0CEF7Q37725339-C2730D30-58AF-4BD5-BC2D-43B48F706A89Q38068962-11A3A782-BB39-4222-9D6F-F48AB8503C90Q38190411-76987C2F-970A-444C-9248-602EB9A4950AQ38215501-6B504202-5283-46D5-B7E5-AB9B2C34FFA7Q38219444-7258DE4D-2BF0-4E68-BF4B-7EFE3A8DBE9EQ38249415-026CF560-E089-43C8-85F9-6C10D21B9AAFQ38293787-23796D20-7AAB-456D-8E57-56528CC1583AQ38344883-754B2BF0-53CF-493B-A560-7772BD7DB8C6Q38412474-0E1B520F-43A1-4DB1-AAD2-D1CE55E96564Q38492052-AB6F2D14-E602-4A5F-9808-A68BF500A6EFQ38527999-04E5F9E7-18B4-4502-A5EE-3D27A895E4F6Q38636313-934E9A1E-9F05-4219-851C-905C78DAD9BBQ38641380-D928DE15-D710-40C2-A73F-9E3A412AB07EQ38657630-317E9F0D-4714-43DF-86D8-60CBDCA70DDA
P2860
Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Fecal calprotectin in predicti ...... alysis of prospective studies.
@ast
Fecal calprotectin in predicti ...... alysis of prospective studies.
@en
Fecal calprotectin in predicti ...... alysis of prospective studies.
@nl
type
label
Fecal calprotectin in predicti ...... alysis of prospective studies.
@ast
Fecal calprotectin in predicti ...... alysis of prospective studies.
@en
Fecal calprotectin in predicti ...... alysis of prospective studies.
@nl
prefLabel
Fecal calprotectin in predicti ...... alysis of prospective studies.
@ast
Fecal calprotectin in predicti ...... alysis of prospective studies.
@en
Fecal calprotectin in predicti ...... alysis of prospective studies.
@nl
P2093
P921
P356
P1476
Fecal calprotectin in predicti ...... alysis of prospective studies.
@en
P2093
Bai-li Chen
Min-hu Chen
Pin-jin Hu
Ying-lian Xiao
P304
P356
10.1002/IBD.22861
P577
2012-01-11T00:00:00Z